Market Cap

As of January 2, 2012: $375,000.00

Stock Chart

ImpediMed - 30 Day Poll

Recent BLOGS About ImpediMed Add New

There are no blogs to display.

Latest Company News

Impedimed Limited Appoints New Chairman
Reuters Key Development - Nov 7, 2011
Impedimed Limited Not To Pay FY 2011 Final Dividend
Reuters Key Development - Aug 30, 2011
Impedimed Limited Not To Pay FY 2011 Interim Dividend
Reuters Key Development - Feb 23, 2011
Impedimed Limited Completes Share Purchase Plan
Reuters Key Development - Jan 27, 2011
Impedimed Limited Announces Share Purchase Plan Offer
Reuters Key Development - Dec 14, 2010
Impedimed Limited Completes Institutional Placement
Reuters Key Development - Dec 1, 2010
Impedimed Limited Announces Management Changes
Reuters Key Development - Oct 17, 2010

Website

Videos related to ImpediMed

Company Profile

ImpediMed is a company engaged in the development, manufacture and sale of bio-impedance instruments to direct customers and distributors. The devices are applied to: monitoring of secondary lymphedema, general health assessment and weight management, muscle wasting, drug dosing and monitoring and sports medicine and fitness.

The Company operates in two segments:


1. Medical, which is a supplier of non-invasive medical devices to two under-served markets, such as the assessment of individuals at risk of secondary lymphoedema and the monitoring of body composition and hydration


2. Test & Measurement, which is a supplier of power precision testing and measuring equipment.


Revenue: Approx. $3.2 million as of 30th June 2009 for th year.


Cash: Approx. $6.6 million as of 30th June 2009


Terms & Rules

As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use

Before using this Biomedical Investing website

OR